Cytokine receptors on macrophages

Cytokine receptors on macrophages represent a broad class of transmembrane proteins that allow macrophages to sense and respond to the immune environment [1]. These receptors include members of the Type I and Type II cytokine receptor families, the Tumor Necrosis Factor (TNF) receptor superfamily, and various chemokine receptors [2]. Their primary biological function is to mediate signal transduction that governs macrophage polarization into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes, as well as their survival and recruitment to sites of injury [3]. In pathological states, such as autoimmune disorders, chronic inflammation, and cancer, the dysregulation of these receptors contributes to tissue damage or the creation of an immunosuppressive tumor microenvironment [4]. Therapeutic strategies often involve monoclonal antibodies that block receptor-ligand interactions or small molecules that inhibit downstream signaling components like Janus kinases (JAKs) [5]. Because macrophages are central to the innate immune response, targeting these receptors provides a potent way to modulate immune activity across a wide range of inflammatory and oncological conditions [6].

Other names

Macrophage cytokine receptorsMonocyte-derived macrophage receptorsMCRs

Drugs targeting these receptors typically function by competitively inhibiting ligand binding to the extracellular domain or by blocking intracellular signaling pathways, such as the JAK/STAT or NF-κB pathways, to modulate macrophage activation and effector functions [5][6].